Cosmos Health Inc (COSM)

NASD · Healthcare · Medical Distribution · Greece

Cosmos Health Inc is a micro cap company (market value under $300 million) in the Medical Distribution industry.

Cosmos Health Inc is a vertically integrated global healthcare company that develops, manufactures, and distributes generic medicines, nutraceuticals, biocides, and medical devices. The company operates across research and development, manufacturing, marketing, sales, and distribution, serving the pharmaceutical and nutraceutical sectors. It also operates a telehealth platform and owns proprietary branded products including Sky Premium Life, Mediterranation, C-Sept, and C-Scrub.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Cosmos Health Inc stock.

Our verdict on COSM

Undervalued: intrinsic value $0.86 per share, market price $0.31, margin of safety 63.8% (as of 2026-10-30).

A 1.2x revenue multiple, discounted for its losses, values the shares at $0.86; the price of $0.31 is 64% below that value.

Leak Score: 51/100 on 9 of 12 signals (Weak Signal).

ETFs with the most weight in COSM

Browse

Peers in Medical Distribution

All 11 Medical Distribution stocks

Is COSM undervalued or overvalued?

COSM is undervalued (as of the 2026-10-30 close). A 1.2x revenue multiple, discounted for its losses, values the shares at $0.86; the price of $0.31 is 64% below that value.

What is the intrinsic value of COSM?

$0.86 per share (as of the 2026-10-30 close), against a market price of $0.31. That is a margin of safety of 63.8%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.

What is Cosmos Health Inc's Leak Score?

51 out of 100, which we rate "Weak Signal", on 9 of 12 value investing signals.